Evaluating Outcomes of Selective Myectomy of Depressor Anguli Oris, Buccinator, and Platysma in Facial Synkinesis
Selective myectomy has gained popularity for treating facial synkinesis.We examined the combined effectiveness of depressor anguli oris (DAO), partial buccinator, and platysma myectomies.Retrospective case series.Pre- and postoperative botulinum toxin-A (BTX-A) treatments of selective myectomy patients were collected. Facial photographs were analyzed using Emotrics + . Facial Asymmetry Index (FAI) and electronic facial paralysis assessment (eFACE) scores were calculated.Twenty patients underwent myectomies. Improvements (mean ± standard error) were seen in several smile metrics, including FAI by 2.80 ± 0.68 mm, nasolabial fold angle by 4.78 ± 1.83 degrees, and smile angle by 4.43 ± 1.18 degrees (all <i>p</i> < 0.05). Postoperative FAI was 2.79 mm. Total BTX-A decreased by 10.85 ± 4.48 units (<i>p</i> = 0.03). eFACE revealed improved oral commissure movement and platysmal synkinesis (<i>p</i> < 0.05 for both).Combined myectomies of the DAO, partial buccinator, and platysma clinically and statistically improve smile in facial synkinesis.
Authors
- Murray J. Bartho (ORCID: https://orcid.org/0000-0003-4864-7850)
- Kayva L. Crawford (ORCID: https://orcid.org/0000-0002-8744-7168)
- Myriam Loyo (ORCID: https://orcid.org/0000-0003-1590-7054)
- Elise Krippaehne (ORCID: https://orcid.org/0009-0004-4540-8891)
Institutions
- Oregon Health & Science University (US)
- Jacksonville College (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Facial Plastic Surgery
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1055/a-2741-2508
- Primary Topic
- Facial Nerve Paralysis Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00